CLOV Insider Sells: Thornton Clay Disposes 16,942 Shares May 19, 2026

Insider trading signals are like financial breadcrumbs. When executives sell shares, investors pay attention. Today we’re tracking a significant insider transaction at CLOV (Clover Health Investments, Corp.). On May 16, 2026, Interim CFO Thornton Joseph Clay disposed of 16,942 shares at $3.47 per share, totaling approximately $58,789. This filing reveals important executive activity worth understanding.

Insider Disposition Details: What Happened

Thornton Joseph Clay, serving as Interim CFO, filed a Form 4 change in ownership on May 18, 2026. The transaction occurred two days earlier on May 16. Clay disposed of 16,942 shares of Class A Common Stock through an F-InKind transaction, which means a non-cash transfer or exchange.

The shares sold at $3.47 each, generating an estimated value of $58,788.74. After this disposition, Clay retained 1.22 million shares in his holdings. This substantial remaining position shows continued confidence in the company despite the recent sale.

Understanding the Transaction Type: F-InKind Explained

An F-InKind transaction is a non-cash disposition. Instead of selling shares for direct payment, the insider transferred securities in exchange for something else of value. This differs from standard open-market sales where cash changes hands immediately.

These transactions often occur through equity compensation arrangements, tax planning strategies, or charitable contributions. The SEC requires disclosure because they represent a change in beneficial ownership. For CLOV’s SEC filing, this disposition signals executive portfolio management activity.

What This Insider Sale Means for CLOV

A single insider sale doesn’t necessarily indicate trouble. Clay’s decision to dispose of shares while retaining 1.22 million suggests measured portfolio rebalancing rather than panic selling. The $3.47 price point reflects current market conditions for Clover Health stock.

Meyka AI rates CLOV a grade of B, factoring in sector performance and financial metrics. This insider activity adds context to the broader investment picture. Investors should monitor whether additional executives follow with similar transactions in coming weeks.

Key Takeaway: Insider Activity in Context

This single disposition by Interim CFO Thornton Clay represents normal executive portfolio management. The F-InKind transaction structure suggests strategic planning rather than distressed selling. With Clay maintaining over 1.2 million shares post-transaction, his confidence in CLOV remains evident.

Insider transactions provide valuable signals, but one trade rarely tells the complete story. Investors should track cumulative insider activity over time to identify meaningful trends at Clover Health.

Final Thoughts

Thornton Joseph Clay’s May 16 disposition of 16,942 CLOV shares at $3.47 represents routine insider portfolio activity. The F-InKind transaction structure indicates strategic management rather than negative sentiment. With Clay retaining 1.22 million shares, his continued stake suggests confidence in Clover Health’s direction. This single transaction should be monitored alongside future insider activity to assess broader executive sentiment toward the company.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.